Eledon Prescription drugs, Inc. (ELDN) Discusses Section II BESTOW Trial Outcomes and Advances in Transplantation Immunosuppression Transcript07/11/2025
Economy & Business 1 Min ReadCullinan Therapeutics: Betting On Zipalertinib NDA CatalystBy Admin16/07/20251 Min ReadCullinan Therapeutics: Betting On Zipalertinib NDA Catalyst
